Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients-Reference-Cited by-同舟云学术

Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients

Published:2019-12-17 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Cui Wanmeng,Luo Wenqi,Zhou Xiaohui,Lu Yunliang,Xu Wenqing,Zhong Suhua,Feng Guofei,Liang Yushan,Liang Libin,Mo Yingxi,Xiao Xue,Huang Guangwu,Matskova Liudmila,Zhang Zhe,Li Ping,Zhou Xiaoying

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference45 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell.,2011

2. Why do cancers have high aerobic glycolysis?;Gatenby;Nat Rev Cancer.,2004

3. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells;Shiraishi;Oncotarget.,2015

4. Links between metabolism and cancer;Dang;Genes Dev.,2012

5. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity;Williams;Cancer Res.,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinoma;Frontiers in Endocrinology;2024-05-17

2. Exploring the Therapeutic Potential of β-Hydroxybutyrate (BHB) in Clear Cell Renal Cell Carcinoma: A Journey into Fat Browning, Autophagy, and Tumor Slimming;International Journal of Clinical Practice;2024-05-15

3. Targeting apoptosis and unfolded protein response: the impact of β-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions;Molecular Biology Reports;2024-01-22

4. Exploring the Significance of SOAT1/ACAT1 in Cancer Pathogenesis;J BIOL REG HOMEOS AG;2024

5. BDH1‐mediated LRRC31 regulation dependent on histone lysine β‐hydroxybutyrylation to promote lung adenocarcinoma progression;MedComm;2023-12